Caterpillar Inc. (NYSE:CAT) has been given an “A-” credit rating by analysts at Morningstar. The firm’s “A-” rating indicates that the company is a low default risk. They also gave their stock a three star rating. On Friday shares of Caterpillar Inc. (NYSE:CAT) closed at $83.21. Company’s sales growth for last 5 years was 11.20% and EPS growth for next 5 years is recorded as 9.69%.
On 30 January, Goldcorp Inc. (NYSE:GG) and the Wabauskang First Nation inked a collaboration agreement that paved the way for long-term economic benefits for the north-western Ontario First Nation. Goldcorp Inc. (NYSE:GG) in last trading activity fell -6.69% to close at $22.89. Company weekly performance is -4.74% while its quarterly performance stands at 29.32%. Goldcorp Inc. (NYSE:GG) is -21.77% away from its 52 week high.
Accuride Corp. (NYSE:ACW) announced that it will be webcasting its investor presentation on Wednesday, February 11, 2015, at the BB&T Capital Markets 30th Annual Transportation Services Conference being held at The Biltmore Hotel in Coral Gables, Fla. On last trading day Accuride Corp. (NYSE:ACW) advanced 0.62% to close at $4.88. Its volatility for the week is 2.90% while volatility for the month is 3.19%. ACW’s sales growth for past 5 years was -7.10% and its EPS growth for past 5 years was 64.10%. Accuride Corp. (NYSE:ACW) monthly performance is 6.09%.
On 5 February, MetLife, Inc. (NYSE:MET) announced that it originated $3.6 billion in agricultural loans in 2014 through its Agricultural Investments Department, an increase of 9 percent year-over-year. MetLife is one of the largest agricultural mortgage lenders in North America. MetLife, Inc. (NYSE:MET) in last trading activity moved up 1.27% to close at $49.60. Company weekly performance is 7.43% while its quarterly performance stands at -8.23%. MetLife, Inc. (NYSE:MET) is -12.38% away from its 52 week high.
On 30 January, Zogenix, Inc. (NASDAQ:ZGNX) announced that the US Food and Drug Administration (FDA) approved its new formulation of Zohydro ER (hydrocodone bitartrate) Extended-Release Capsules, CII, with BeadTek. On last trading day Zogenix, Inc. (NASDAQ:ZGNX) increased 2.36% to close at $1.30. Its volatility for the week is 7.59% while volatility for the month is 6.38%. ZGNX’s EPS growth for past 5 years was 57.40%. Zogenix, Inc. (NASDAQ:ZGNX) monthly performance is -6.47%.